ARTICLE | Management Tracks
Resilience hires Rubius, Novartis vet Fisk as CTO
Plus: Seely named president and CEO at Lyell, and updates from Codagenix, Vigil, Hookipa and Cybrexa
December 16, 2022 1:43 AM UTC
Biomanufacturing company National Resilience Inc. hired Spencer Fisk as CTO. Fisk was SVP and chief technical operations officer at Rubius Therapeutics Inc. (NASDAQ:RUBY), before which he held senior roles at Novartis AG (SIX:NOVN; NYSE:NVS). Resilience has raised $1.4 billion to create advanced biomanufacturing capacity in North America for biologics, vaccines, nucleic acids and cell and gene therapies.
T cell therapy company Lyell Immunopharma Inc. (NASDAQ:LYEL) named Lynn Seely as president and CEO. Seely succeeds Liz Homans, who will remain a consultant through June 2024. Seely was president and CEO at Myovant Sciences GmbH (NYSE:MYOV), and joined Lyell as board member in 2021...